Statins and non-alcoholic steatohepatitis

Journal of Hepatology

Volumn 64, Issue 1, 2016, Pages 241-242

  Athyros, Vasilios G ^a   Katsiki, Niki ^b   Karagiannis, Asterios ^a   Mikhailidis, Dimitri P ^b  

^a ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; ASPARTATE AMINOTRANSFERASE; ATORVASTATIN; GAMMA GLUTAMYLTRANSFERASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN; LIVER ENZYME; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPASE; ROSUVASTATIN; SIMVASTATIN; SYNAPSIN II; VERY LOW DENSITY LIPOPROTEIN;

ALCOHOL ABUSE; DISEASE SEVERITY; DYSLIPIDEMIA; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; LETTER; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROSPECTIVE STUDY; STEATOSIS; ALCOHOLIC FATTY LIVER; FATTY LIVER;

FATTY LIVER; FATTY LIVER, ALCOHOLIC; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; NON-ALCOHOLIC FATTY LIVER DISEASE;

EID: 84951047448     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.09.021     Document Type: Letter

References (9)

1. P. Dongiovanni, S. Petta, V. Mannisto, R.M. Mancina, R. Pipitone, V. Karja, and et al. Statin use and non-alcoholic steatohepatitis in at risk individuals J Hepatol 63 2015 705 712
2. C. Pirazzi, M. Adiels, M.A. Burza, R.M. Mancina, M. Levin, M. Ståhlman, and et al. Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro J Hepatol 57 2012 1276 1282
3. V.G. Athyros, K. Tziomalos, T.D. Gossios, T. Griva, P. Anagnostis, K. Kargiotis, and et al. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a posthoc analysis Lancet 376 2010 1916 1922
4. V.G. Athyros, O. Giouleme, E.S. Ganotakis, M. Elisaf, K. Tziomalos, T. Vassiliadis, and et al. Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study Arch Med Sci 7 2011 796 805
5. M.J. Tikkanen, R. Fayyad, O. Faergeman, A.G. Olsson, C.C. Wun, R. Laskey, and et al. Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels Int J Cardiol 168 2013 3846 3852
6. L. Eslami, S. Merat, R. Malekzadeh, S. Nasseri-Moghaddam, and H. Aramin Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis Cochrane Database Syst Rev 12 2013 CD008623
7. V.G. Athyros, K. Tziomalos, N. Katsiki, M. Doumas, A. Karagiannis, and D.P. Mikhailidis Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: an update World J Gastroenterol 21 2015 6820 6834
8. A. Nelson, D.M. Torres, A.E. Morgan, C. Fincke, and S.A. Harrison A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: a randomized placebo-controlled trial J Clin Gastroenterol 43 2009 990 994
9. K. Kargiotis, V.G. Athyros, O. Giouleme, N. Katsiki, E. Katsiki, P. Anagnostis, and et al. Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome World J Gastroenterol 21 2015 7860 7868